{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:30:09Z","timestamp":1787596209831,"version":"build-2736575974"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":1124,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.5604\/16652681.1198799","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T08:04:31Z","timestamp":1459843471000},"page":"303-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Angiogenesis and portal-systemic collaterals in portal hypertension"],"prefix":"10.1016","volume":"15","author":[{"given":"Juan Crist\u00f3bal","family":"Gana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina A.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/16652681.1198799_bib0005","first-page":"58","article-title":"Detection of chronic liver disease: costs and benefits.","volume":"5","author":"Quinn","year":"1997","journal-title":"Gastroenterologist"},{"key":"10.5604\/16652681.1198799_bib0010","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.1840200611","article-title":"Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study.","volume":"20","author":"Bellentani","year":"1994","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0020","first-page":"983","article-title":"A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices.","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198799_bib0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMra003007","article-title":"Gastroesophageal variceal hemorrhage.","volume":"345","author":"Sharara","year":"2001","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198799_bib0030","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/hep.22273","article-title":"Portal hypertension and variceal bleeding\u2014unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference.","volume":"47","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-3476(00)09680-3","article-title":"Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction.","volume":"136","author":"Lykavieris","year":"2000","journal-title":"J Pediatr"},{"key":"10.5604\/16652681.1198799_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-3468(00)90203-3","article-title":"Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial.","volume":"35","author":"Goncalves","year":"2000","journal-title":"J Pediatr Surg"},{"key":"10.5604\/16652681.1198799_bib0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/mpd.2001.115967","article-title":"Survival after first esophageal variceal hemorrhage in patients with biliary atresia.","volume":"139","author":"Miga","year":"2001","journal-title":"J Pediatr"},{"key":"10.5604\/16652681.1198799_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jpedsurg.2003.09.019","article-title":"Portoenterostomy for biliary atresia: Long-term survival and prognosis after esophageal variceal bleeding.","volume":"39","author":"van Heurn","year":"2004","journal-title":"J Pediatr Surg"},{"key":"10.5604\/16652681.1198799_bib0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3476(84)80120-1","article-title":"Long-term prognosis in biliary atresia after hepatic portoenterostomy: analysis of 35 patients who survived beyond 5 years of age.","volume":"105","author":"Kobayashi","year":"1984","journal-title":"J Pediatr"},{"key":"10.5604\/16652681.1198799_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3468(78)80212-7","article-title":"Extrahepatic portal hypertension: a review of 70 cases.","volume":"13","author":"Mitra","year":"1978","journal-title":"J Pediatr Surg"},{"key":"10.5604\/16652681.1198799_bib0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MPG.0b013e3181b64437","article-title":"Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children.","volume":"50","author":"Gana","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.5604\/16652681.1198799_bib0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1053\/j.gastro.2011.08.049","article-title":"A clinical prediction rule and platelet count predict esophageal varices in children.","volume":"141","author":"Gana","year":"2011","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198799_bib0075","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/0022-3468(93)90440-V","article-title":"Outcome of 21 patients with biliary atresia living more than 10 years.","volume":"28","author":"Toyosaka","year":"1993","journal-title":"J Pediatr Surg"},{"key":"10.5604\/16652681.1198799_bib0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis.","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N Engl J Med"},{"key":"10.5604\/16652681.1198799_bib0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12072-015-9613-5","article-title":"New cellular and molecular targets for the treatment of portal hypertension.","volume":"9","author":"Gracia-Sancho","year":"2015","journal-title":"Hepatol Int"},{"key":"10.5604\/16652681.1198799_bib0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jhep.2007.03.014","article-title":"Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers","volume":"47","author":"Gracia-Sancho","year":"2007","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5085(98)70487-1","article-title":"Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.","volume":"114","author":"Rockey","year":"1998","journal-title":"Gastroenterology"},{"issue":"Suppl. 5","key":"10.5604\/16652681.1198799_bib0100","first-page":"34","article-title":"Role of hepatic stellate cells in the pathogenesis of portal hypertension.","volume":"22","author":"Marra","year":"2002","journal-title":"Nefrologia"},{"key":"10.5604\/16652681.1198799_bib0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3748\/wjg.v19.i11.1707","article-title":"Current concepts on the role of nitric oxide in portal hypertension","volume":"19","author":"Hu","year":"2013","journal-title":"World J. Gastroenterol"},{"key":"10.5604\/16652681.1198799_bib0110","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","article-title":"Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells.","volume":"170","author":"Novo","year":"2007","journal-title":"Am J Pathol"},{"key":"10.5604\/16652681.1198799_bib0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21564","article-title":"Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?","volume":"45","author":"Lee","year":"2007","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.20193","article-title":"Angiogenesis in chronic inflammatory liver disease.","volume":"39","author":"Medina","year":"2004","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis: from the bench to clinical targets.","volume":"36","author":"Pinzani","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.5604\/16652681.1198799_bib0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease.","volume":"50","author":"Fernandez","year":"2009","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00695054","article-title":"The scarring of the liver acini (Cirrhosis). Tridimensional and microcirculatory considerations.","volume":"402","author":"Rappaport","year":"1983","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.5604\/16652681.1198799_bib0140","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/jhep.2000.18658","article-title":"Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats.","volume":"32","author":"Wang","year":"2000","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0145","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1053\/j.gastro.2008.07.065","article-title":"Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.","volume":"135","author":"Taura","year":"2008","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198799_bib0150","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.27318","article-title":"Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles.","volume":"61","author":"Lemoinne","year":"2015","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0155","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.","volume":"46","author":"Tugues","year":"2007","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0160","series-title":"Schiff\u2019s diseases of the liver","first-page":"429","article-title":"Portal hypertension","author":"Bosch","year":"2003"},{"key":"10.5604\/16652681.1198799_bib0165","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0170","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.20905","article-title":"High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.","volume":"42","author":"Riggio","year":"2005","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0175","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome.","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"key":"10.5604\/16652681.1198799_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastroesophageal varices and variceal bleeding.","volume":"5","author":"Garcia-Tsao","year":"1985","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0185","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0190","first-page":"G1043","article-title":"NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.","volume":"276","author":"Wiest","year":"1999","journal-title":"Am J Physiol"},{"key":"10.5604\/16652681.1198799_bib0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4254\/wjh.v2.i6.208","article-title":"Physiopathology of splanchnic vasodilation in portal hypertension.","volume":"2","author":"Martell","year":"2010","journal-title":"World J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0200","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis.","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.5604\/16652681.1198799_bib0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4254\/wjh.v7.i3.377","article-title":"Angiogenesis and liver fibrosis.","volume":"7","author":"Elpek","year":"2015","journal-title":"World J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fonc.2014.00131","article-title":"Orchestration of angiogenesis by immune cells.","volume":"4","author":"Bruno","year":"2014","journal-title":"Front Oncol"},{"key":"10.5604\/16652681.1198799_bib0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease.","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198799_bib0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2014.02.015","article-title":"Cellular and molecular mechanisms in liver fibrogenesis.","volume":"548","author":"Novo","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.5604\/16652681.1198799_bib0225","doi-asserted-by":"crossref","first-page":"272170","DOI":"10.1155\/2010\/272170","article-title":"Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma.","volume":"2010","author":"Sanz-Cameno","year":"2010","journal-title":"J Oncol"},{"key":"10.5604\/16652681.1198799_bib0230","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/path.3005","article-title":"The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells.","volume":"226","author":"Novo","year":"2012","journal-title":"J Pathol"},{"key":"10.5604\/16652681.1198799_bib0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/mic.10.1.83.97","article-title":"Arteriogenesis: the development and growth of collateral arteries.","volume":"10","author":"Helisch","year":"2003","journal-title":"Microcirculation"},{"key":"10.5604\/16652681.1198799_bib0240","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.RES.79.5.1015","article-title":"Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat.","volume":"79","author":"Unthank","year":"1996","journal-title":"Circ Res"},{"key":"10.5604\/16652681.1198799_bib0245","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/01.ATV.19.8.1825","article-title":"Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors.","volume":"19","author":"Nagel","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.5604\/16652681.1198799_bib0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.15.1.2","article-title":"Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress.","volume":"15","author":"Walpola","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.5604\/16652681.1198799_bib0255","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1006\/jmcc.2000.1137","article-title":"Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis.","volume":"32","author":"Cai","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.5604\/16652681.1198799_bib0260","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1073\/pnas.92.17.8069","article-title":"The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression.","volume":"92","author":"Shyy","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.5604\/16652681.1198799_bib0265","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/19546","article-title":"MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.","volume":"398","author":"Gerszten","year":"1999","journal-title":"Nature"},{"key":"10.5604\/16652681.1198799_bib0270","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.","volume":"271","author":"Clauss","year":"1996","journal-title":"J Biol Chem"},{"key":"10.5604\/16652681.1198799_bib0275","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1078\/0171-9335-00113","article-title":"Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression.","volume":"79","author":"Heil","year":"2000","journal-title":"Eur J Cell Biol"},{"key":"10.5604\/16652681.1198799_bib0280","doi-asserted-by":"crossref","first-page":"188998","DOI":"10.2174\/092986712800099848","article-title":"Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress.","volume":"19","author":"Kaji","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.5604\/16652681.1198799_bib0285","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.510290436","article-title":"Increased angiogenesis in portal hypertensive rats: role of nitric oxide.","volume":"29","author":"Sumanovski","year":"1999","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0290","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1440-1746.2001.02452.x","article-title":"Immunohistochemical localization of vascular endothelial growth factor in the rat portal hypertensive gastropathy.","volume":"16","author":"Tsugawa","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1198799_bib0295","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.","volume":"35","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0300","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2003.12.012","article-title":"Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.","volume":"126","author":"Fernandez","year":"2004","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198799_bib0305","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.","volume":"43","author":"Fernandez","year":"2005","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0310","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/gut.2005.088013","article-title":"NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.","volume":"56","author":"Angermayr","year":"2007","journal-title":"Gut"},{"key":"10.5604\/16652681.1198799_bib0315","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jhep.2012.07.012","article-title":"Adenoviral dominantnegative soluble PDGFR\u03b1 improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.","volume":"57","author":"Reichenbach","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0320","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.gastro.2008.04.010","article-title":"Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.","volume":"135","author":"Semela","year":"2008","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198799_bib0325","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.22467","article-title":"The hepatic apelin system: a new therapeutic target for liver disease.","volume":"48","author":"Principe","year":"2008","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0330","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2008.09.019","article-title":"Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.","volume":"50","author":"Tiani","year":"2009","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0335","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1582-4934.2008.00218.x","article-title":"The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats.","volume":"12","author":"Mejias","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.5604\/16652681.1198799_bib0340","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","article-title":"Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.","volume":"51","author":"Reiberger","year":"2009","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0345","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0350","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.24427","article-title":"Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.","volume":"54","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2036.2011.04896.x","article-title":"The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma-a pilot study.","volume":"35","author":"Pinter","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198799_bib0360","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.22872","article-title":"Antiangiogenic therapy: not just for cancer anymore?","volume":"49","author":"Shah","year":"2009","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0365","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1053\/j.gastro.2009.08.068","article-title":"Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension.","volume":"137","author":"Van Steenkiste","year":"2009","journal-title":"Gastroenterology"},{"key":"10.5604\/16652681.1198799_bib0370","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/hep.24238","article-title":"Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.","volume":"53","author":"Van Steenkiste","year":"2011","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0375","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1476-5381.2009.00158.x","article-title":"Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.","volume":"157","author":"Hennenberg","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.5604\/16652681.1198799_bib0380","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0385","doi-asserted-by":"crossref","first-page":"G1191","DOI":"10.1152\/ajpgi.00252.2011","article-title":"Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.","volume":"302","author":"D\u2019Amico","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.5604\/16652681.1198799_bib0390","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gut.52.9.1347","article-title":"Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.","volume":"52","author":"Yoshiji","year":"2003","journal-title":"Gut"},{"key":"10.5604\/16652681.1198799_bib0395","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI200421152","article-title":"Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.","volume":"114","author":"Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"10.5604\/16652681.1198799_bib0400","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hep.26995","article-title":"Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.","volume":"60","author":"Coch","year":"2014","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0405","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.27061","article-title":"Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor\/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases.","volume":"60","author":"Chatterjee","year":"2014","journal-title":"Hepatology"},{"key":"10.5604\/16652681.1198799_bib0410","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/gutjnl-2014-307138","article-title":"Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile ductligated portal hypertensive rats.","volume":"64","author":"Mejias","year":"2015","journal-title":"Gut"},{"key":"10.5604\/16652681.1198799_bib0415","doi-asserted-by":"crossref","first-page":"e16978","DOI":"10.1371\/journal.pone.0016978","article-title":"Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib","volume":"6","author":"Coriat","year":"2011","journal-title":"PLoS One"},{"key":"10.5604\/16652681.1198799_bib0420","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1200\/JCO.2001.19.4.1207","article-title":"Clinical implications of circulating angiogenic factors in cancer patients.","volume":"19","author":"Poon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.5604\/16652681.1198799_bib0425","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.SLA.0000059986.96051.EA","article-title":"Endothelial-directed hepatic regeneration after partial hepatectomy.","volume":"237","author":"Greene","year":"2003","journal-title":"Ann Surg"},{"key":"10.5604\/16652681.1198799_bib0430","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science"},{"key":"10.5604\/16652681.1198799_bib0435","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0002-9440(10)63351-2","article-title":"Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease","volume":"165","author":"Ward","year":"2004","journal-title":"Am J Pathol"},{"key":"10.5604\/16652681.1198799_bib0440","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0046-8177(98)90205-2","article-title":"Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.","volume":"29","author":"Torimura","year":"1998","journal-title":"Hum Pathol"},{"key":"10.5604\/16652681.1198799_bib0445","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1440-1746.2011.06887.x","article-title":"Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma.","volume":"26","author":"Miyahara","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/16652681.1198799_bib0450","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3748\/wjg.v11.i8.1167","article-title":"Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.","volume":"11","author":"Enjoji","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.5604\/16652681.1198799_bib0455","first-page":"296","article-title":"Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension.","volume":"5","author":"Assy","year":"1999","journal-title":"World J Gastroenterol"},{"key":"10.5604\/16652681.1198799_bib0460","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1018863718430","article-title":"Serum vascular endothelial growth factor levels in various liver diseases.","volume":"43","author":"Akiyoshi","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.5604\/16652681.1198799_bib0465","first-page":"1261","article-title":"Vascular endothelial growth factor levels in liver cirrhosis.","volume":"44","author":"Genesca","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.5604\/16652681.1198799_bib0470","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2013.01.005","article-title":"Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis.","volume":"58","author":"Waidmann","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/16652681.1198799_bib0475","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2036.2012.05134.x","article-title":"Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.","volume":"36","author":"Gr\u00f8nbaek","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/16652681.1198799_bib0480","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2012.07245.x","article-title":"Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.","volume":"28","author":"Yang","year":"2013","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119306490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119306490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/publisherspanel.com\/icid\/pdf\/1198799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:35:43Z","timestamp":1761647743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119306490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1665268119306490"],"URL":"https:\/\/doi.org\/10.5604\/16652681.1198799","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenesis and portal-systemic collaterals in portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/16652681.1198799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}